Askin tumors are highly malignant small-round-cell tumors of the thoracopul
monary region, which occur rarely. Therefore, we report on our experiences
with eight patients (5 male, 3 females). who were treated in our department
between 11'94 and 10'97 (age: 9-40 years, mean age: 20.5 years). All Askin
tumors were diagnosed by histological and immunohistochemical examinations
as well as moleculargenetic proof of characteristic translocations. In all
patients, the tumor arose from the chest wall, infiltrating adjacent ribs
and parts of the lung. At the time of first diagnosis, five patients did no
t reveal any metastases. One patient suffered from intrapulmonary metastase
s and two patients from an infiltration of the diaphragm and of adjacent ve
rtebral bodies. Treatment consisted of a pre- and postoperative (radio-) ch
emotherapy according to the EVAIA protocol and a radical tumor resection in
all patients. The postoperative course was uneventful in seven patients, o
ne patient suffered from pneumonia after multiple wedge resections for intr
apulmonary metastases. Four patients, in whom primary tumor resection was c
omplete, are alive 14, 20, 35 and 84 months after first diagnosis - only on
e patient had to undergo a second operation for a local relapse 17 months a
fter first diagnosis. The other 4 patients, who suffered from a very extens
ive primary tumor, expired 13, 17, 18 and 39 months after the diagnosis was
made. Our data demonstrate that Askin tumors require an aggressive multimo
dality treatment consisting of pre- and postoperative chemotherapy, radical
surgical resection and postoperative irradiation, which may be performed p
reoperatively in selected cases, too.